SPRB
SPRUCE BIOSCIENCES, INC.
Key Financials
Operating Income
$-36513000
↑ 35.0%
Net Income
$-38966000
↑ 26.5%
Revenue
$0
↓ 100.0%
Total Liabilities
$10.5M
↓ 35.9%
Total Assets
$53.0M
↑ 17.3%
Shareholders' Equity
$42.5M
↑ 47.5%
EPS (Diluted)
$-50.83
↓ 3840.3%
Cash & Equivalents
$48.9M
↑ 26.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| ARS | 4/9/2026 | View on SEC |
| DEFA14A | 4/9/2026 | View on SEC |
| DEF 14A | 4/9/2026 | View on SEC |
| 8-K | 3/20/2026 | View on SEC |
| 4 | 3/9/2026 | View on SEC |
| 3 | 3/9/2026 | View on SEC |
| 424B5 | 3/9/2026 | View on SEC |
| S-8 | 3/9/2026 | View on SEC |
| 8-K | 3/9/2026 | View on SEC |
| 10-K | 3/9/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | SPRB |
| Company Name | SPRUCE BIOSCIENCES, INC. |
| CIK | 1683553 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (415) 655-4168 |